3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
7
Leukemia, Biphenotypic, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Large B-Cell, Diffuse
2
Hematologic Neoplasms
2
Prostatic Neoplasms
1
Pneumonia
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma
1
Lymphohistiocytosis, Hemophagocytic
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hepatectomy
1
Drug-Related Side Effects and Adverse Reactions
1
Down Syndrome
1
Brain Neoplasms
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Acute Gout
1
Interventions
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Cyclophosphamide
2
Busulfan
2
Azacitidine
2
venetoclax
1
pevonedistat
1
fludarabine
1
fedratinib
1
Transplantation
1
Sirolimus
1
Radiotherapy
1
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
1
Methotrexate
1
Melphalan
1
Etoposide
1
Cyclosporine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Neutrophilic, Chronic
×
Methylprednisolone
×
90 days
×
Clear all
No trials found.